Literature DB >> 19471286

Coronary artery disease: Complex coronary disease in the post-SYNTAX era.

Giuseppe Tarantini.   

Abstract

Should patients with high-risk coronary artery disease be treated with CABG or receive drug-eluting stents? The SYNTAX trial aimed to define the optimal revascularization strategy for patients with previously untreated three-vessel and/or left main coronary artery disease.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19471286     DOI： 10.1038/nrcardio.2009.75

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  6 in total

1.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).

Authors:  Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-01-03       Impact factor: 24.094

2.  Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II).

Authors:  Alexandre C Pereira; Neuza H M Lopes; Paulo R Soares; Jose Eduardo Krieger; Sergio A de Oliveira; Luiz A M Cesar; Jose A F Ramires; Whady Hueb
Journal:  J Am Coll Cardiol       Date:  2006-08-17       Impact factor: 24.094

3.  Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease.

Authors:  R H Jones; K Kesler; H R Phillips; D B Mark; P K Smith; C L Nelson; M F Newman; J G Reves; R W Anderson; R M Califf
Journal:  J Thorac Cardiovasc Surg       Date:  1996-05       Impact factor: 5.209

4.  PCI versus CABG for multivessel coronary disease in diabetics.

Authors:  Giuseppe Tarantini; Angelo Ramondo; Massimo Napodano; Enrico Favaretto; Arianna Gardin; Claudio Bilato; Georghios Nesseris; Vincenzo Tarzia; Filippo Cademartiri; Gino Gerosa; Sabino Iliceto
Journal:  Catheter Cardiovasc Interv       Date:  2009-01-01       Impact factor: 2.692

5.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

6.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

Authors:  S Yusuf; D Zucker; P Peduzzi; L D Fisher; T Takaro; J W Kennedy; K Davis; T Killip; E Passamani; R Norris
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.